| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |